Inhibitors of fatty acid amide hydrolase
First Claim
1. A pharmaceutically acceptable composition, comprising a compound of formula III,
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention provide compounds, and pharmaceutical compositions thereof, encompassed by the formulae (I), (II) or (III).
The present invention also provides methods for treating an FAAH mediated disease, disorder or condition by administering a therapeutically effective amount of a provided compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof. Additionally, the present invention provides methods for inhibiting FAAH in a patient by administering a therapeutically effective amount of a compound of the formulae (I), (II) or (III), or a pharmaceutical composition thereof, to a patient in need thereof.
126 Citations
16 Claims
- 1. A pharmaceutically acceptable composition, comprising a compound of formula III,
- 14. A method for treating a fatty acid amide hydrolase (FAAH)-mediated disease, disorder, or condition by administering a therapeutically effective amount of a compound of formula III,
Specification